Dicker A, Kaaman M, van Harmelen V, Aström G, Blanc K L, Rydén M
Department of Medicine, Karolinska University Hospital, Stockholm, Sweden.
Int J Obes (Lond). 2005 Dec;29(12):1413-21. doi: 10.1038/sj.ijo.0803042.
Human adipocytes can be obtained in vitro by differentiation of human preadipocytes or mesenchymal stem cells (hMSC). Although functionally similar to freshly isolated cells, no detailed comparison of the different cell types has been performed. The antilipolytic alpha2A-adrenoceptor (AR) and the cAMP-degrading enzyme Phosphodiesterase-3B (PDE3B) have been implicated in the fine-tuning of lipolysis but little is known regarding their role in human adipocytes nor whether their expression and/or function differs in fat cells from different precursors.
The effects of alpha2A-AR and PDE3B inhibition in mature adipocytes was determined and compared to that in differentiated preadipocytes and hMSC-derived fat cells. Gene expression was determined by real-time PCR and protein expression by Western blot.
Noradrenaline (NA) stimulated lipolysis in preadipocytes and mature adipocytes but markedly reduced lipolysis in differentiated hMSC derived-adipocytes. This was due to a potent stimulation of alpha2A-AR since co-incubation with NA and the alpha2-AR-inhibitor yohimbine restored NA-induced lipolysis. The order of Yohimbine response was hMSC>preadipocytes>mature adipocytes. Although alpha2-AR mRNA expression was highest in mature adipocytes there was no difference in alpha2A-AR protein levels between the cell types. In contrast, Galphai2 mRNA and protein expression was significantly higher in MSC-derived adipocytes, suggesting that differences in the response to alpha2A-AR inhibition reside at the postreceptor level. Incubation with the cAMP-analog 8-bromo(8b) cAMP increased lipolysis in hMSC-derived fat cells while co-incubation with the PDE3-specific inhibitor OPC3911 did not alter the lipolytic effect. In contrast, OPC3911 increased 8bcAMP-induced lipolysis significantly in preadipocytes and mature adipocytes. The response to PDE3B inhibition was; mature adipocytes>preadipocytes>hMSC a finding that correlated significantly with both PDE3B mRNA expression and enzymatic activity.
Although differentiated adipocytes of different origins display similar functional characteristics there are important differences in the regulation of lipolysis with a marked alpha2A-AR and less pronounced PDE3B effect in fat cells from MSCs.
人脂肪细胞可通过人前脂肪细胞或间充质干细胞(hMSC)分化在体外获得。尽管其功能与新鲜分离的细胞相似,但尚未对不同细胞类型进行详细比较。抗脂解的α2A -肾上腺素能受体(AR)和降解cAMP的磷酸二酯酶-3B(PDE3B)参与了脂解的精细调节,但它们在人脂肪细胞中的作用以及在来自不同前体的脂肪细胞中其表达和/或功能是否存在差异尚不清楚。
测定α2A - AR和PDE3B抑制对成熟脂肪细胞的影响,并与分化的前脂肪细胞和hMSC来源的脂肪细胞进行比较。通过实时PCR测定基因表达,通过蛋白质印迹法测定蛋白质表达。
去甲肾上腺素(NA)刺激前脂肪细胞和成熟脂肪细胞的脂解,但显著降低分化的hMSC来源脂肪细胞的脂解。这是由于α2A - AR的强烈刺激,因为与NA和α2 - AR抑制剂育亨宾共同孵育可恢复NA诱导的脂解。育亨宾反应的顺序为hMSC>前脂肪细胞>成熟脂肪细胞。尽管α2 - AR mRNA表达在成熟脂肪细胞中最高,但不同细胞类型之间α2A - AR蛋白水平没有差异。相反,Gαi2 mRNA和蛋白表达在MSC来源的脂肪细胞中显著更高,这表明对α2A - AR抑制反应的差异存在于受体后水平。与cAMP类似物8 -溴(8b)cAMP孵育可增加hMSC来源脂肪细胞的脂解,而与PDE3特异性抑制剂OPC3911共同孵育并未改变脂解作用。相反,OPC3911在显著增加前脂肪细胞和成熟脂肪细胞中8bcAMP诱导的脂解。对PDE3B抑制的反应为:成熟脂肪细胞>前脂肪细胞>hMSC,这一结果与PDE3B mRNA表达和酶活性均显著相关。
尽管不同来源的分化脂肪细胞表现出相似的功能特征,但在脂解调节方面存在重要差异,在MSC来源的脂肪细胞中α2A - AR作用明显而PDE3B作用较弱。